HomeXFOR • NASDAQ
add
X4 Pharmaceuticals Inc
Previous close
$3.30
Day range
$3.20 - $3.40
Year range
$1.35 - $26.83
Market cap
37.19M USD
Avg Volume
7.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.97M | 250.44% |
Operating expense | 27.88M | -18.46% |
Net income | -25.74M | -128.34% |
Net profit margin | -1.30K | -108.09% |
Earnings per share | -3.47 | -63.88% |
EBITDA | -25.88M | 23.22% |
Effective tax rate | -0.14% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.95M | -62.70% |
Total assets | 105.17M | -50.07% |
Total liabilities | 101.20M | -12.88% |
Total equity | 3.97M | — |
Shares outstanding | 11.41M | — |
Price to book | 6.60 | — |
Return on assets | -55.77% | — |
Return on capital | -71.68% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -25.74M | -128.34% |
Cash from operations | -29.90M | 1.24% |
Cash from investing | 23.11M | -76.14% |
Cash from financing | 5.63M | -72.07% |
Net change in cash | -1.02M | -101.17% |
Free cash flow | -20.77M | 4.39% |
About
Founded
Mar 13, 2019
Headquarters
Website
Employees
143
